Document Type : Original Article
Authors
Personalized Medicine Research Center of AmitisGen, Tehran, Iran
Abstract
Nonalcoholic fatty liver disease (NAFLD) is a common cause of chronic liver disease. Non-alcoholic fatty liver disease is a spectrum of simple steatosis that is benign to non-alcoholic steatohepatitis (NASH) associated with fibrosis and inflammation. Genetic factors play an important role in this disease. The PNPLA3 gene (C > G) rs738409 polymorphism has been defined to be associated with increased liver fat content and liver damage in metabolic disorders. In this study, the association of this polymorphism with non-alcoholic fatty liver disease was investigated in the Mazandaran province population. Our study population consisted of 85 patients and 85 controls. Blood samples were collected from patients and DNA were then extracted by boiling method. Genotypes of this polymorphism were determined by PCR-RFLP method. There was a significant relationship between CG genotype and risk of NAFLD (P = 0.012).
Keywords
Esfahani MM, Khadem A. Fatty Liver Disease From the
Perspective of Traditional Iranian Medicine. Quran Med.
2012;1(4):117-8. doi: 10.5812/quranmed.11092
2. Savadkooh F, Hosseini Tabatabai M, Shahabinejad S. [The
prevalence of fatty liver on ultrasound patients without a
history of liver disease and its association with cholesterol and
triglyceride]. TabibShargh. 2003;5(3):177-83.
3. Orangi E, Ostadrahimi A, Mahdavi R, Svmy M, Tarzmani M.
[Indicators related to oxidative stress and antioxidant status in
patients with nonalcoholic fatty liver]. J EndocrinolMetab.
2010;12(5):499-3.
4. Rotman Y, Koh C, Zmuda JM, Kleiner DE, Liang TJ, Nash
CRN. The association of genetic variability in patatin-like
phospholipase domain-containing protein 3 (PNPLA3) with
histological severity of nonalcoholic fatty liver disease.
Hepatology. 2010;52(3):894-903. doi: 10.1002/hep.23759
pmid: 20684021
5. Valenti L, Alisi A, Galmozzi E, Bartuli A, Del Menico B, Alterio
A, et al. I148M patatin-like phospholipase domain-containing
3 gene variant and severity of pediatric nonalcoholic fatty liver
disease. Hepatology. 2010;52(4):1274-80. doi:
10.1002/hep.23823 pmid: 20648474
6. Zain SM, Mohamed R, Mahadeva S, Cheah PL, Rampal S, Basu
RC, et al. A multi-ethnic study of a PNPLA3 gene variant and
its association with disease severity in non-alcoholic fatty liver
disease. Hum Genet. 2012;131(7):1145-52. doi:
10.1007/s00439-012-1141-y pmid: 22258181
7. Romeo S, Huang-Doran I, Baroni MG, Kotronen A.
Unravelling the pathogenesis of fatty liver disease: patatin-like
phospholipase domain-containing 3 protein. Curr Opin
Lipidol. 2010;21(3):247-52. doi:
10.1097/mol.0b013e328338ca61 pmid: 20480550
8. Kotronen A, Peltonen M, Hakkarainen A, Sevastianova K,
Bergholm R, Johansson LM, et al. Prediction of non-alcoholic
fatty liver disease and liver fat using metabolic and genetic
factors. Gastroenterology. 2009;137(3):865-72. doi:
10.1053/j.gastro.2009.06.005 pmid: 19524579
9. Sohrabpour AA, Rezvan H, Amini-Kafiabad S, Dayhim M,
Merat S, Pourshams A. Prevalence of nonalcoholic
steatohepatitis in Iran: a population based study. Middle East J
Digest Dis. 2010;2(1):14.
10. Alavian SM, Mohammad-Alizadeh AH, Esna-Ashari F, Ardalan
G, Hajarizadeh B. Non-alcoholic fatty liver disease prevalence
among school-aged children and adolescents in Iran and its
association with biochemical and anthropometric measures.
Liver Int. 2009;29(2):159-63. doi: 10.1111/j.1478-
3231.2008.01790.x pmid: 18492015
11. Lankarani KB, Ghaffarpasand F, Mahmoodi M, Lotfi M,
Zamiri N, Heydari ST, et al. Non alcoholic fatty liver disease in
southern Iran: a population based study. Hepat Mon.
2013;13(5):e9248. doi: 10.5812/hepatmon.9248 pmid:
23922564
12. Baulande S, Lasnier F, Lucas M, Pairault J. Adiponutrin, a
transmembrane protein corresponding to a novel dietary- and
obesity-linked mRNA specifically expressed in the adipose
lineage. J Biol Chem. 2001;276(36):33336-44. doi:
10.1074/jbc.M105193200 pmid: 11431482
13. Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D,
Pennacchio LA, et al. Genetic variation in PNPLA3 confers
susceptibility to nonalcoholic fatty liver disease. Nat Genet.
2008;40(12):1461-5. doi: 10.1038/ng.257 pmid: 18820647
14. Sanyal AJ, American Gastroenterological A. AGA technical
review on nonalcoholic fatty liver disease. Gastroenterology.
2002;123(5):1705-25. doi: 10.1053/gast.2002.36572 pmid:
12404245
15. Chang CY. Understanding the relationship between PNPLA3,
NAFLD and insulin resistance: do ethnic differences bring
more questions or more answers? Liver Int. 2011;31(9):1246-
9. doi: 10.1111/j.1478-3231.2011.02612.x pmid: 22093451
16. Li Q, Qu HQ, Rentfro AR, Grove ML, Mirza S, Lu Y, et al.
PNPLA3 polymorphisms and liver aminotransferase levels in a
Mexican American population. Clin Invest Med.
2012;35(4):E237-45. doi: 10.25011/cim.v35i4.17153 pmid:
22863562
)